Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
J Infect Dis
    September 2022
  1. URIU K, Cardenas P, Munoz E, Barragan V, et al
    Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection.
    J Infect Dis. 2022;226:1200-1203.
    >> Share

  2. SMITH MSR, Mohan H, Ajaykumar A, Hsieh AYY, et al
    Second-generation HIV integrase inhibitors induce differentiation dysregulation and exert toxic effects in human embryonic stem cell and mouse models.
    J Infect Dis. 2022 Sep 19. pii: 6704757. doi: 10.1093.
    >> Share

  3. PELUSO MJ, Mitchell A, Wang CY, Takahashi S, et al
    Low Prevalence of Interferon-alpha Autoantibodies in People Experiencing Long COVID Symptoms.
    J Infect Dis. 2022 Sep 12. pii: 6696027. doi: 10.1093.
    >> Share

  4. MARGOT NA, Naik V, VanderVeen L, Anoshchenko O, et al
    Resistance analyses in Highly Treatment-Experienced People with HIV Treated with the Novel Capsid HIV Inhibitor Lenacapavir.
    J Infect Dis. 2022 Sep 9. pii: 6694734. doi: 10.1093.
    >> Share

  5. GAYEDYU-DENNIS D, Fallah MP, Drew C, Badio M, et al
    Identifying pauci-/asymptomatic and unrecognized Ebola virus disease among close contacts based on exposure risk assessments and screening algorithms.
    J Infect Dis. 2022 Sep 1. pii: 6679723. doi: 10.1093.
    >> Share

    August 2022
  6. HWA SH, Snyman J, Bernstein M, Ganga Y, et al
    HIV viremia is associated with compromised SARS-CoV-2 Beta variant neutralization.
    J Infect Dis. 2022 Aug 17. pii: 6670446. doi: 10.1093.
    >> Share

  7. GARDNER AR, Ma Y, Bacchetti P, Price JC, et al
    Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
    J Infect Dis. 2022 Aug 11. pii: 6650396. doi: 10.1093.
    >> Share

  8. SAMSUNDER N, de Vos M, Ngcapu S, Giandhari J, et al
    Clinical evaluation of SARS-CoV-2 rapid antigen tests during the Omicron wave in South Africa.
    J Infect Dis. 2022 Aug 3. pii: 6654839. doi: 10.1093.
    >> Share

    July 2022
  9. BABALOLA CM, Siebert JC, Kallapur SG, Maecker HT, et al
    Discrete Plasma Cytokine Profiles among Pregnant Women in Botswana by Chlamydia trachomatis infection, HIV status, and Gestational age.
    J Infect Dis. 2022 Jul 25. pii: 6649668. doi: 10.1093.
    >> Share

  10. TORIBIO M, Wilks MQ, Hedgire S, Lu MT, et al
    Increased Macrophage-Specific Arterial Infiltration Relates to Non-calcified Plaque and Systemic Immune Activation in People with HIV.
    J Infect Dis. 2022 Jul 20. pii: 6646962. doi: 10.1093.
    >> Share

  11. MAHANT A, Guerguis S, Blevins TP, Cheshenko N, et al
    Herpes Simplex Virus Glycoprotein D Antibodies Fail to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines.
    J Infect Dis. 2022 Jul 14. pii: 6644507. doi: 10.1093.
    >> Share

  12. ROGANDO AC, Weber KM, Xing J, Xue X, et al
    The IDOze Study: The Link between Sleep Disruption and Tryptophan-Kynurenine Pathway Activation in Women with HIV.
    J Infect Dis. 2022 Jul 8. pii: 6633821. doi: 10.1093.
    >> Share

  13. COSSU MV, Mileto D, Giacomelli A, Oreni L, et al
    Does the co-morbidity burden contribute to suboptimal immunological responses to COVID-19 vaccination in people living with HIV?
    J Infect Dis. 2022 Jul 7. pii: 6633353. doi: 10.1093.
    >> Share

    June 2022
  14. HUNIDZARIRA P, Brown ER, Chirenje ZM, Hillier SL, et al
    Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials.
    J Infect Dis. 2022 Jun 28. pii: 6619245. doi: 10.1093.
    >> Share

  15. LLIBRE JM, Revollo B, Aguilar S, Calomarde-Gomez C, et al
    Protection against severe clinical outcomes with adenovirus or mRNA SARS-CoV-2 vaccines in patients hospitalized with Covid-19.
    J Infect Dis. 2022 Jun 28. pii: 6619237. doi: 10.1093.
    >> Share

  16. HICKEY MD, Imbert E, Appa A, Del Rosario JB, et al
    HIV treatment outcomes in POP-UP: drop-in HIV primary care model for people experiencing homelessness.
    J Infect Dis. 2022 Jun 27. pii: 6618638. doi: 10.1093.
    >> Share

  17. MOODIE Z, Dintwe O, Sawant S, Grove D, et al
    Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.
    J Infect Dis. 2022 Jun 27. pii: 6618597. doi: 10.1093.
    >> Share

  18. NYAWANDA BO, Otieno NA, Otieno MO, Emukule GO, et al
    The Impact of Maternal Human Immunodeficiency Virus Infection on the Burden of Respiratory Syncytial Virus Among Pregnant Women and Their Infants, Western Kenya.
    J Infect Dis. 2022;225:2097-2105.
    >> Share

  19. CUSTER B, Grebe E, Buccheri R, Bakkour S, et al
    Surveillance for Zika, chikungunya and dengue virus incidence and RNAemia in blood donors at four Brazilian blood centers during 2016-2019.
    J Infect Dis. 2022 Jun 11. pii: 6605709. doi: 10.1093.
    >> Share

  20. QUINN MK, Williams PL, Muhihi A, Duggan CP, et al
    Timing of antiretroviral therapy initiation and birth outcomes among pregnant women living with HIV in Tanzania.
    J Infect Dis. 2022 Jun 9. pii: 6604810. doi: 10.1093.
    >> Share

  21. JACOBSON JM
    Immune Responses to SARS-CoV-2 Vaccination in People With HIV: A Tale of Two Pandemics.
    J Infect Dis. 2022 Jun 7. pii: 6603522. doi: 10.1093.
    >> Share

  22. LAPOINTE HR, Mwimanzi F, Cheung PK, Sang Y, et al
    People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.
    J Infect Dis. 2022 Jun 7. pii: 6603521. doi: 10.1093.
    >> Share

  23. TAYLOR SA, Sharma S, Remmel CAL, Holder B, et al
    HIV-associated alterations of the biophysical features of maternal antibodies correlate with their reduced transfer across the placenta.
    J Infect Dis. 2022 Jun 6. pii: 6603519. doi: 10.1093.
    >> Share

    May 2022
  24. MWIMANZI F, Lapointe HR, Cheung PK, Sang Y, et al
    Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose.
    J Infect Dis. 2022 May 11. pii: 6583561. doi: 10.1093.
    >> Share

  25. KOLOSSVARY M, deFilippi C, Lu MT, Zanni MV, et al
    Proteomic Signature of Subclinical Coronary Artery Disease in People with HIV: Analysis of the REPRIEVE Mechanistic Substudy.
    J Infect Dis. 2022 May 10. pii: 6583088. doi: 10.1093.
    >> Share

  26. CINDI Z, Kawuma AN, Maartens G, Bradford Y, et al
    Pharmacogenetics of dolutegravir plasma exposure among Southern Africans living with HIV.
    J Infect Dis. 2022 May 4. pii: 6580078. doi: 10.1093.
    >> Share

  27. MOHAREB AM, Liu AF, Kim AY, Coffie PA, et al
    Clearance of hepatitis B "e" antigen in untreated chronic HBV infection: a systematic review and meta-analysis.
    J Infect Dis. 2022 May 2. pii: 6576758. doi: 10.1093.
    >> Share

  28. GIBBS A, Healy K, Kaldhusdal V, Sundling C, et al
    MAIT cells are preserved in the cervical mucosa of HIV-infected women and exhibit a dominant expression of the TRAV1-2-TRAJ20 TCRalpha chain.
    J Infect Dis. 2022 May 2. pii: 6576501. doi: 10.1093.
    >> Share

  29. JACOBS JL, Naqvi A, Shah FA, Boltz VF, et al
    Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19.
    J Infect Dis. 2022 May 2. pii: 6576503. doi: 10.1093.
    >> Share

  30. WALKER NF, Karim F, Moosa M, Moodley S, et al
    Elevated Plasma Matrix Metalloproteinase-8 associates with Sputum Culture Positivity in Pulmonary Tuberculosis.
    J Infect Dis. 2022 May 1. pii: 6576469. doi: 10.1093.
    >> Share

    April 2022
  31. CHAUDRON SE, Leemann C, Kusejko K, Nguyen H, et al
    A systematic molecular epidemiology screen reveals numerous HIV-1 superinfections in the Swiss HIV Cohort Study.
    J Infect Dis. 2022 Apr 29. pii: 6575836. doi: 10.1093.
    >> Share

  32. PETERSEN KJ, Strain J, Cooley S, Vaida F, et al
    Machine learning quantifies accelerated white-matter aging in persons with HIV.
    J Infect Dis. 2022 Apr 28. pii: 6575226. doi: 10.1093.
    >> Share

  33. SPATOLA M, Loos C, Cizmeci D, Webb N, et al
    Functional compartmentalization of antibodies in the central nervous system during chronic HIV infection.
    J Infect Dis. 2022 Apr 13. pii: 6568136. doi: 10.1093.
    >> Share

  34. MUGO C, Nduati R, Osoro E, Nyawanda BO, et al
    Comparable pregnancy outcomes for HIV-uninfected and HIV-infected women on antiretroviral treatment in Kenya.
    J Infect Dis. 2022 Apr 11. pii: 6566248. doi: 10.1093.
    >> Share

  35. AFRAN L, Jambo KC, Nedi W, Miles DJC, et al
    Defective monocyte enzymatic function and an inhibitory immune phenotype in HIV-exposed uninfected African infants in the era of antiretroviral therapy.
    J Infect Dis. 2022 Apr 11. pii: 6566242. doi: 10.1093.
    >> Share

  36. LOUVANTO K, Baral P, Burchell A, Ramanakumar A, et al
    Role of Human Leukocyte Antigen Allele Sharing in Human Papillomavirus Infection Transmission Among Heterosexual Couples: Findings From the Hitch Cohort Study.
    J Infect Dis. 2022 Apr 1. pii: 6562380. doi: 10.1093.
    >> Share

  37. EDFELDT G, Lajoie J, Rohl M, Oyugi J, et al
    Regular Use of Depot Medroxyprogesterone Acetate Causes Thinning of the Superficial Lining and Apical Distribution of Human Immunodeficiency Virus Target Cells in the Human Ectocervix.
    J Infect Dis. 2022;225:1151-1161.
    >> Share

    March 2022
  38. REEVES RM, van Wijhe M, Lehtonen T, Stona L, et al
    A Systematic Review of European Clinical Practice Guidelines for Respiratory Syncytial Virus Prophylaxis.
    J Infect Dis. 2022 Mar 25. pii: 6554001. doi: 10.1093.
    >> Share

  39. WEI F, Xia N, Ocampo R, Goodman MT, et al
    Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies.
    J Infect Dis. 2022 Mar 23. pii: 6553063. doi: 10.1093.
    >> Share

  40. TOVINH M, Horr G, Dobrikova K, Gotter C, et al
    Mitochondrial dysfunction contributes to impaired cytokine production of CD56 bright NK cells from HIV(+) individuals under effective antiviral therapy.
    J Infect Dis. 2022 Mar 21. pii: 6551690. doi: 10.1093.
    >> Share

  41. ESHLEMAN SH, Fogel JM, Piwowar-Manning E, Chau G, et al
    Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
    J Infect Dis. 2022 Mar 18. pii: 6549543. doi: 10.1093.
    >> Share

  42. RINDLER AE, Kusejko K, Kuster H, Neumann K, et al
    The interplay between replication capacity of HIV-1 and surrogate markers of disease.
    J Infect Dis. 2022 Mar 17. pii: 6550309. doi: 10.1093.
    >> Share

  43. POVEDA E, Tabernilla A, Fitzgerald W, Salgado-Barreira A, et al
    Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control.
    J Infect Dis. 2022;225:1040-1049.
    >> Share

  44. KROON E, Chottanapund S, Buranapraditkun S, Sacdalan C, et al
    Paradoxically greater persistence of HIV RNA+ cells in lymphoid tissue when ART is initiated in the earliest stage of infection.
    J Infect Dis. 2022 Mar 11. pii: 6547240. doi: 10.1093.
    >> Share

  45. TANKO RF, Bunjun R, Dabee S, Jaumdally SZ, et al
    The Effect Of Contraception On Genital Cytokines In Women Randomized To Copper Intrauterine Device, Intramuscular Depot Medroxyprogesterone Acetate Or Levonorgestrel Implant.
    J Infect Dis. 2022 Mar 9. pii: 6545868. doi: 10.1093.
    >> Share

  46. HALL EW, Weng MK, Harris AM, Schillie S, et al
    Assessing the cost-utility of universal hepatitis B vaccination among adults.
    J Infect Dis. 2022 Mar 9. pii: 6545195. doi: 10.1093.
    >> Share

  47. VAN KAMPEN JJA, Dalm VASH, Fraaij PLA, Oude Munnink BB, et al
    Clinical and in-vitro evidence favoring immunoglobulin treatment of a chronic norovirus infection in a patient with common variable immunodeficiency.
    J Infect Dis. 2022 Mar 7. pii: 6543890. doi: 10.1093.
    >> Share

    February 2022
  48. BOTTANELLI M, Ceccarelli D, Galli L, Castagna A, et al
    Response to Cyktor Et Al.
    J Infect Dis. 2022 Feb 26. pii: 6537607. doi: 10.1093.
    >> Share

  49. TEPEKULE B, Kusejko K, Zeeb M, Tarr PE, et al
    Impact of Latent Tuberculosis Infection on the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study.
    J Infect Dis. 2022 Feb 16. pii: 6529706. doi: 10.1093.
    >> Share

  50. PAVLINAC P, Singa B, Huang ML, Shrestha L, et al
    Cytomegalovirus viremia predicts post-discharge mortality in Kenyan HIV-exposed uninfected children.
    J Infect Dis. 2022 Feb 13. pii: 6527814. doi: 10.1093.
    >> Share

  51. BOSCH RJ, Gandhi RT, Mar H, Eron JJ, et al
    Associations between multiple measures of HIV-1 persistence on suppressive antiretroviral therapy.
    J Infect Dis. 2022 Feb 4. pii: 6522965. doi: 10.1093.
    >> Share

  52. MAHOMED S, Garrett N, Capparelli EV, Osman F, et al
    Safety and pharmacokinetics of monoclonal antibodies VRC07-523LS and PGT121 administered subcutaneously for HIV prevention.
    J Infect Dis. 2022 Feb 4. pii: 6522857. doi: 10.1093.
    >> Share

  53. SMITH RA, Wu VH, Song J, Raugi DN, et al
    Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations In HIV-2 Integrase: A Phenotypic Analysis Using An Expanded Panel of Site-Directed Mutants.
    J Infect Dis. 2022 Feb 3. pii: 6521074. doi: 10.1093.
    >> Share

  54. LAU JSY, Cromer D, Pinkevych M, Lewin SR, et al
    Balancing statistical power and risk in HIV cure clinical trial design.
    J Infect Dis. 2022 Feb 1. pii: 6519358. doi: 10.1093.
    >> Share

    January 2022
  55. LAURIE C, El-Zein M, Tota J, Khosrow-Khavar F, et al
    Efficacy of a carrageenan gel in increasing clearance of anal HPV infections in men: interim analysis of a double-blind randomized controlled trial.
    J Infect Dis. 2022 Jan 28. pii: 6516990. doi: 10.1093.
    >> Share

  56. GELPI M, Vestad B, Raju SC, Hansen SH, et al
    Association of the kynurenine pathway of tryptophan metabolism with HIV-related gut microbiota alterations and visceral adipose tissue accumulation.
    J Infect Dis. 2022 Jan 28. pii: 6516797. doi: 10.1093.
    >> Share

  57. ZURCHER K, Riou J, Morrow C, Ballif M, et al
    Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data.
    J Infect Dis. 2022 Jan 18. pii: 6510424. doi: 10.1093.
    >> Share

  58. ZHANG Y, D'Souza G, Fakhry C, Bigelow EO, et al
    Oral HPV associated with differences in oral microbiota beta diversity and microbiota abundance.
    J Infect Dis. 2022 Jan 17. pii: 6509880. doi: 10.1093.
    >> Share

  59. KHALFI P, Suspene R, Caval V, Thiers V, et al
    APOBEC3C S188I polymorphism enhances context specific editing of Hepatitis B virus genome.
    J Infect Dis. 2022 Jan 12. pii: 6504007. doi: 10.1093.
    >> Share

  60. L'HONNEUR AS, Pipoli Da Fonseca J, Cokelaer T, Rozenberg F, et al
    JC Polyomavirus whole genome sequencing at the single molecule level reveals emerging neurotropic populations in Progressive Multifocal Leucoencephalopathy.
    J Infect Dis. 2022 Jan 3. pii: 6494525. doi: 10.1093.
    >> Share

    December 2021
  61. LUCIER A, Fong Y, Li SH, Dennis M, et al
    Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV.
    J Infect Dis. 2021 Dec 28. pii: 6486389. doi: 10.1093.
    >> Share

  62. WEITZMANN MN, Weiss D, Vikulina T, Roser-Page S, et al
    Immune Reconstitution Bone Loss Exacerbates Bone Degeneration Due to Natural Aging in a Mouse Model.
    J Infect Dis. 2021 Dec 28. pii: 6485936. doi: 10.1093.
    >> Share

  63. VERBURGH ML, Boyd A, Wit FWNM, Schim van der Loeff MF, et al
    Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV.
    J Infect Dis. 2021 Dec 20. pii: 6470931. doi: 10.1093.
    >> Share

  64. SAHA A, Escudero J, Layouni T, Richardson B, et al
    Mycobacterium tuberculosis-specific T cell responses are impaired during late pregnancy with elevated biomarkers of tuberculosis risk postpartum.
    J Infect Dis. 2021 Dec 20. pii: 6470923. doi: 10.1093.
    >> Share

  65. VILLALBA JA, Maus MV, Frigault MJ, Zaffini R, et al
    False-positive HIV testing in patients receiving lentivirus-based chimeric antigen receptor T-cell therapy: A case report, review of the literature and proposed recommendations.
    J Infect Dis. 2021 Dec 20. pii: 6470480. doi: 10.1093.
    >> Share

  66. SCHOEPF IC, Thorball CW, Ledergerber B, Kootstra NA, et al
    Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years.
    J Infect Dis. 2021 Dec 15. pii: 6463311. doi: 10.1093.
    >> Share

  67. POERIO N, Caccamo N, La Manna MP, Olimpieri T, et al
    Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages.
    J Infect Dis. 2021 Dec 15. pii: 6463308. doi: 10.1093.
    >> Share

  68. BROCKMAN MA, Mwimanzi F, Lapointe HR, Sang Y, et al
    Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults.
    J Infect Dis. 2021 Dec 9. pii: 6458430. doi: 10.1093.
    >> Share

  69. MASWIME S, Pule C, Mtshali Z, Chawana R, et al
    HIV, Placental Lesions, and Adverse Perinatal Outcomes.
    J Infect Dis. 2021;224.
    >> Share

  70. AUSTIN MN, Meyn LA, Avolia HA, Petrina MA, et al
    Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females.
    J Infect Dis. 2021 Dec 4. pii: 6449486. doi: 10.1093.
    >> Share

  71. KATSUYA H, Cook LBM, Rowan AG, Melamed A, et al
    Erratum to: Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.
    J Infect Dis. 2021 Dec 4. pii: 6449345. doi: 10.1093.
    >> Share

    November 2021
  72. FULDA ES, Fitch KV, Overton ET, Zanni MV, et al
    COVID-19 Vaccination Rates in a Global HIV Cohort.
    J Infect Dis. 2021 Nov 18. pii: 6431673. doi: 10.1093.
    >> Share

  73. BALAKRISHNA S, Wolfensberger A, Kachalov V, Roth JA, et al
    Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study.
    J Infect Dis. 2021 Nov 18. pii: 6430793. doi: 10.1093.
    >> Share

  74. DUARTE G, Muresan P, Ward S, Laimon L, et al
    Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV.
    J Infect Dis. 2021 Nov 16. pii: 6429421. doi: 10.1093.
    >> Share

  75. STOCKDALE AJ, Meiring JE, Shawa IT, Thindwa D, et al
    Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi.
    J Infect Dis. 2021 Nov 9. pii: 6424415. doi: 10.1093.
    >> Share

    October 2021
  76. STERN J, Solomon A, Dantanarayana A, Pascoe R, et al
    Cell-associated HIV RNA has a Circadian Cycle in Males Living with HIV on Antiretroviral Therapy.
    J Infect Dis. 2021 Oct 16. pii: 6398479. doi: 10.1093.
    >> Share

  77. ARRIAGA MB, Araujo-Pereira M, Barreto-Duarte B, Nogueira B, et al
    The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study.
    J Infect Dis. 2021 Oct 15. pii: 6398049. doi: 10.1093.
    >> Share

  78. SMITH JA, Garnett GP, Hallett TB
    The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modeling Study.
    J Infect Dis. 2021;224:1179-1186.
    >> Share

  79. ROTH JA, Radevski G, Marzolini C, Rauch A, et al
    Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study.
    J Infect Dis. 2021;224:1198-1208.
    >> Share

  80. STONE M, Rosenbloom DIS, Bacchetti P, Deng X, et al
    Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size.
    J Infect Dis. 2021;224:1209-1218.
    >> Share

  81. VERBOEKET SO, Wit FW, Verheij E, van Zoest RA, et al
    Human Immunodeficiency Virus (HIV)-Negative Men Who Have Sex With Men Have Higher CD8+ T-Cell Counts and Lower CD4+/CD8+ T-Cell Ratios Compared With HIV-Negative Heterosexual Men.
    J Infect Dis. 2021;224:1187-1197.
    >> Share

  82. TINGGAARD M, Slotved HC, Fuursted K, Storgaard M, et al
    Oral and anal carriage of Streptococcus pneumoniae among sexually active men with HIV who have sex with men.
    J Infect Dis. 2021 Oct 8. pii: 6383604. doi: 10.1093.
    >> Share

  83. AKATA K, Leung JM, Yamasaki K, Filho FSL, et al
    Altered polarization and impaired phagocytic activity of lung macrophages in people with HIV and COPD.
    J Infect Dis. 2021 Oct 5. pii: 6381638. doi: 10.1093.
    >> Share

  84. LECUYER R, Issa N, Tessoulin B, Lavergne RA, et al
    Epidemiology and clinical impact of respiratory co-infections at diagnosis of Pneumocystis jirovecii Pneumonia.
    J Infect Dis. 2021 Oct 4. pii: 6380657. doi: 10.1093.
    >> Share

    September 2021
  85. PELUSO MJ, Lu S, Tang AF, Durstenfeld MS, et al
    Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021 Sep 27. pii: 6376537. doi: 10.1093.
    >> Share

  86. GAY CL, James KS, Tuyishime M, Falcinelli SD, et al
    Stable Latent HIV Infection and Low-Level Viremia Despite Treatment with the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
    J Infect Dis. 2021 Sep 25. pii: 6375363. doi: 10.1093.
    >> Share

  87. WARD KM, Falade-Nwulia O, Moon J, Sutcliffe CG, et al
    Non-adherence to LDV/SOF did not predict SVR in a randomized controlled trial of HIV/HCV coinfected persons who use drugs.
    J Infect Dis. 2021 Sep 20. pii: 6372878. doi: 10.1093.
    >> Share

  88. WALKER J, Soeters HM, Novak R, Diallo AO, et al
    Modeling Optimal Laboratory Testing Strategies for Bacterial Meningitis Surveillance in Africa.
    J Infect Dis. 2021;224.
    >> Share

    August 2021
  89. PETERS BA, Moon JY, Hanna DB, Kutsch O, et al
    T-cell immune dysregulation and mortality in women with HIV.
    J Infect Dis. 2021 Aug 27. pii: 6358605. doi: 10.1093.
    >> Share

  90. VAN DER HEIJDEN WA, van Deuren RC, van de Wijer L, van den Munckhof ICL, et al
    Clonal hematopoiesis is associated with low CD4 nadir and increased residual HIV transcriptional activity in virally suppressed individuals with HIV.
    J Infect Dis. 2021 Aug 21. pii: 6356061. doi: 10.1093.
    >> Share

  91. GOODEN TE, Gardner M, Wang J, Jolly K, et al
    Incidence of cardiometabolic diseases in people living with and without HIV in the UK: a population-based matched cohort study.
    J Infect Dis. 2021 Aug 21. pii: 6356062. doi: 10.1093.
    >> Share

  92. PALICH R, Teyssou E, Sayon S, Abdi B, et al
    Kinetics of archived M184V mutation in treatment-experienced virally suppressed HIV-infected patients.
    J Infect Dis. 2021 Aug 20. pii: 6355381. doi: 10.1093.
    >> Share

  93. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years.
    J Infect Dis. 2021;224:657-666.
    >> Share

  94. SORTINO O, Dias J, Anderson M, Laidlaw E, et al
    Preserved Mucosal-Associated Invariant T-Cell Numbers and Function in Idiopathic CD4 Lymphocytopenia.
    J Infect Dis. 2021;224:715-725.
    >> Share

  95. HEARPS AC, Angelovich TA, Trevillyan JM, Wong ME, et al
    Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular Risk.
    J Infect Dis. 2021;224:667-672.
    >> Share

  96. MCMAHON DK, Zheng L, Cyktor JC, Aga E, et al
    A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy.
    J Infect Dis. 2021;224:648-656.
    >> Share

  97. KREISEL KM, Llata E, Haderxhanaj L, Pearson WS, et al
    The Burden of and Trends in Pelvic Inflammatory Disease in the United States, 2006-2016.
    J Infect Dis. 2021;224.
    >> Share

  98. DAVIS GS, Horner PJ, Price MJ, Mitchell HD, et al
    What Do Diagnoses of Pelvic Inflammatory Disease in Specialist Sexual Health Services in England Tell Us About Chlamydia Control?
    J Infect Dis. 2021;224.
    >> Share

  99. PIETROBON AJ, Yoshikawa FSY, Oliveira LM, Pereira NZ, et al
    Antiviral Response Induced by TLR7/TLR8 Activation Inhibits HIV-1 Infection in Cord Blood Macrophages.
    J Infect Dis. 2021 Aug 6. pii: 6342784. doi: 10.1093.
    >> Share

    July 2021
  100. GIL RM, Freeman T, Mathew T, Kullar R, et al
    The LGBTQ+ communities and the COVID-19 pandemic: a call to break the cycle of structural barriers.
    J Infect Dis. 2021 Jul 29. pii: 6330600. doi: 10.1093.
    >> Share

  101. DA SILVA J, Pals S, Chang J, Hackett S, et al
    Monitoring emerging HIV drug resistance in sub-Saharan Africa in the era of dolutegravir.
    J Infect Dis. 2021 Jul 20. pii: 6324299. doi: 10.1093.
    >> Share

  102. DURAN RAMIREZ JJ, Ballouz T, Nguyen H, Kusejko K, et al
    Increasing Frequency and Transmission of HIV-1 Non-B Subtypes among Men Who Have Sex with Men in the Swiss HIV Cohort Study.
    J Infect Dis. 2021 Jul 14. pii: 6321357. doi: 10.1093.
    >> Share

  103. RONIT A, Omland LH, Kronborg G, Pedersen G, et al
    Incidence of chronic obstructive pulmonary disease in people with HIV, their parents and siblings in Denmark.
    J Infect Dis. 2021 Jul 14. pii: 6321339. doi: 10.1093.
    >> Share

  104. SPRADLING PR, Xing J, Harris AM, Ly KN, et al
    Estimated prevalence and number of persons with isolated antibody to hepatitis B core antigen and associated occult hepatitis B, United States, 2001-2018.
    J Infect Dis. 2021 Jul 12. pii: 6319558. doi: 10.1093.
    >> Share

  105. GUMBO A, Topazian HM, Mwanza A, Mitchell CL, et al
    Occurrence and Distribution of Non-falciparum Malaria Parasite Species among Adolescents and Adults in Malawi.
    J Infect Dis. 2021 Jul 9. pii: 6318237. doi: 10.1093.
    >> Share

  106. BOWMAN NM, Balasubramanian S, Gilman RH, Parobek C, et al
    Deep sequencing to detect diversity of Trypanosoma cruzi infection in patients co-infected with HIV and Chagas disease.
    J Infect Dis. 2021 Jul 8. pii: 6317582. doi: 10.1093.
    >> Share

    June 2021
  107. PETERS BA, Xue X, Sheira LA, Qi Q, et al
    Menopause is associated with immune activation in women with HIV.
    J Infect Dis. 2021 Jun 26. pii: 6310126. doi: 10.1093.
    >> Share

  108. ESTEBAN-CANTOS A, Montejano R, Rodriguez-Centeno J, Saiz-Medrano G, et al
    Longitudinal changes in epigenetic age acceleration in aviremic HIV-infected recipients of long-term antiretroviral treatment.
    J Infect Dis. 2021 Jun 24. pii: 6309028. doi: 10.1093.
    >> Share

  109. GHOSN J, Assoumou L, Lascoux-Combe C, Peytavin G, et al
    HIV-1-RNA kinetics in blood plasma and in seminal plasma of men starting a dolutegravir-based triple-combination regimen at the time of primary HIV-1 infection.
    J Infect Dis. 2021 Jun 24. pii: 6309026. doi: 10.1093.
    >> Share

  110. BRAUNSTEIN SL, Slutsker JS, Lazar R, Shah D, et al
    Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City.
    J Infect Dis. 2021 Jun 16. pii: 6301136. doi: 10.1093.
    >> Share

  111. ROSENBERG ES, Tesoriero JM
    A Tale of Many New York Cities.
    J Infect Dis. 2021 Jun 4. pii: 6291934. doi: 10.1093.
    >> Share

  112. RAGONNET-CRONIN M, Golubchik T, Moyo S, Fraser C, et al
    HIV genetic diversity informs stage of HIV-1 infection among patients receiving antiretroviral therapy in Botswana.
    J Infect Dis. 2021 Jun 2. pii: 6291357. doi: 10.1093.
    >> Share

    May 2021
  113. KINLOCH NN, Ritchie G, Brumme CJ, Dong W, et al
    Corrigendum to: Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results.
    J Infect Dis. 2021 May 31. pii: 6289906. doi: 10.1093.
    >> Share

  114. HORSBURGH BA, Hiener B, Fisher K, Lee E, et al
    Cellular activation, differentiation and proliferation influence the dynamics of genetically-intact proviruses over time.
    J Infect Dis. 2021 May 26. pii: 6284332. doi: 10.1093.
    >> Share

  115. RAVINDRAN J, Richardson B, Kinuthia J, Unger JA, et al
    Chlamydia, gonorrhea, and incident HIV infection during pregnancy predict preterm birth despite treatment.
    J Infect Dis. 2021 May 23. pii: 6282455. doi: 10.1093.
    >> Share

  116. SCHNITTMAN SR, Deitchman AN, Beck-Engeser G, Ahn H, et al
    Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus.
    J Infect Dis. 2021;223:1621-1630.
    >> Share

  117. MUKERJI SS, Misra V, Lorenz DR, Chettimada S, et al
    Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.
    J Infect Dis. 2021;223:1601-1611.
    >> Share

  118. TAMARGO JA, Hernandez-Boyer J, Teeman C, Martin HR, et al
    Immune activation: A link between food insecurity and chronic disease in people living with HIV.
    J Infect Dis. 2021 May 16. pii: 6276422. doi: 10.1093.
    >> Share

  119. CHA S, Henry A, Montgomery MP, Laws RL, et al
    Morbidity and Mortality among Adults Experiencing Homelessness Hospitalized with COVID-19.
    J Infect Dis. 2021 May 16. pii: 6276529. doi: 10.1093.
    >> Share

  120. BRUCE-BRAND C, Schubert PT, Wright CA
    HIV, placental pathology and birth outcomes - a brief overview.
    J Infect Dis. 2021 May 14. pii: 6275456. doi: 10.1093.
    >> Share

  121. GABRIELAITE M, Bennedbaek M, Zucco AG, Ekenberg C, et al
    Human immunotypes impose selection on viral genotypes through viral epitope specificity.
    J Infect Dis. 2021 May 11. pii: 6273783. doi: 10.1093.
    >> Share

  122. GUERRERO-MARTIN SM, Rubin LH, McGee KM, Shirk EN, et al
    Psychosocial Stress Alters the Immune Response and Results in Higher Viral Load During Acute SIV Infection in a Pigtailed Macaque Model of HIV.
    J Infect Dis. 2021 May 10. pii: 6273219. doi: 10.1093.
    >> Share

  123. MILLAR JR, Bengu N, Vieira VA, Adland E, et al
    Early initiation of antiretroviral therapy following in utero HIV infection is associated with low viral reservoirs but other factors determine subsequent plasma viral rebound.
    J Infect Dis. 2021 May 8. pii: 6272368. doi: 10.1093.
    >> Share

  124. MCFARLAND EJ, Cunningham CK, Muresan P, Capparelli EV, et al
    Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
    J Infect Dis. 2021 May 2. pii: 6261970. doi: 10.1093.
    >> Share

    April 2021
  125. LY KN, Xing J, Spradling PR
    Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018.
    J Infect Dis. 2021 Apr 27. pii: 6254685. doi: 10.1093.
    >> Share

  126. BEBELL LM, Parks K, Le MH, Ngonzi J, et al
    Placental decidual arteriopathy and vascular endothelial growth factor A (VEGF-A) expression among women with and without HIV.
    J Infect Dis. 2021 Apr 21. pii: 6242421. doi: 10.1093.
    >> Share

  127. IKUMI NM, Pillay K, Tilburgs T, Malaba TR, et al
    T cell Homeostatic Imbalance in Placentae from Women with HIV in the absence of Vertical Transmission.
    J Infect Dis. 2021 Apr 21. pii: 6242402. doi: 10.1093.
    >> Share

  128. KALA S, Meteleva K, Serghides L
    ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection.
    J Infect Dis. 2021 Apr 21. pii: 6242371. doi: 10.1093.
    >> Share

  129. BARES SH, Smeaton LM, Scott SE, Smith BA, et al
    The Association Between Weight Gain, Sex and Immune Activation Following the Initiation of Antiretroviral Therapy.
    J Infect Dis. 2021 Apr 19. pii: 6236102. doi: 10.1093.
    >> Share

  130. TAILOR J, Foldi J, Generoso M, McCarty B, et al
    Disease Progression in Children with Perinatal HIV Correlates with Increased PD-1+ CD8 T Cells that Coexpress Multiple Immune Checkpoints.
    J Infect Dis. 2021 Apr 17. pii: 6231805. doi: 10.1093.
    >> Share

  131. KATSUYA H, Cook LBM, Rowan AG, Melamed A, et al
    Clonality of HIV-1 and HTLV-1 infected cells in naturally coinfected individuals.
    J Infect Dis. 2021 Apr 12. pii: 6222242. doi: 10.1093.
    >> Share

  132. ERLANDSON KM, Wilson MP, MaWhinney S, Rapaport E, et al
    The Impact of Moderate or High-Intensity Combined Exercise on Systemic Inflammation Among Older Persons With and Without HIV.
    J Infect Dis. 2021;223:1161-1170.
    >> Share

  133. VINHAES CL, Sheikh V, Oliveira-de-Souza D, Wang J, et al
    An Inflammatory Composite Score Predicts Mycobacterial Immune Reconstitution Inflammatory Syndrome in People with Advanced HIV: A Prospective International Cohort Study.
    J Infect Dis. 2021;223:1275-1283.
    >> Share

  134. EISINGER RW, Lerner AM, Fauci AS
    HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics.
    J Infect Dis. 2021 Apr 7. pii: 6167835. doi: 10.1093.
    >> Share

  135. RAFFENBERG M, Engel T, Schoepf IC, Kootstra NA, et al
    Impact of Delaying Antiretroviral Treatment during Primary HIV Infection on Telomere Length.
    J Infect Dis. 2021 Apr 5. pii: 6211111. doi: 10.1093.
    >> Share

  136. KENYON C
    Dual azithromycin/ceftriaxone therapy for gonorrhoea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold.
    J Infect Dis. 2021 Apr 2. pii: 6209316. doi: 10.1093.
    >> Share

  137. JANSEN K, Selb R, Banhart S, Buder S, et al
    Reponse to Kenyon.
    J Infect Dis. 2021 Apr 2. pii: 6209317. doi: 10.1093.
    >> Share

    March 2021
  138. LOHMAN-PAYNE B, Koster J, Gabriel B, Chilengi R, et al
    Persistent Immune activation in HIV-Infected Pregnant Women Initiating cART Post Conception.
    J Infect Dis. 2021 Mar 29. pii: 6199840. doi: 10.1093.
    >> Share

  139. MAFFEI VJ, Siggins RW, Luo M, Brashear MM, et al
    Alcohol Use Is Associated With Intestinal Dysbiosis and Dysfunctional CD8+ T-Cell Phenotypes in Persons With Human Immunodeficiency Virus.
    J Infect Dis. 2021;223:1029-1039.
    >> Share

  140. BLAZKOVA J, Huiting ED, Boddapati AK, Shi V, et al
    TIGIT expression on CD8+ T cells correlates with higher cytotoxic capacity.
    J Infect Dis. 2021 Mar 21. pii: 6179305. doi: 10.1093.
    >> Share

  141. MARZINKE MA, Grinsztejn B, Fogel JM, Piwowar-Manning E, et al
    Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083.
    J Infect Dis. 2021 Mar 19. pii: 6178946. doi: 10.1093.
    >> Share

  142. GOUPIL DE BOUILLE J, Vigouroux C, Plessis L, Ghislain M, et al
    Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy : socio-clinical, inflammation, and metabolic markers.
    J Infect Dis. 2021 Mar 19. pii: 6178947. doi: 10.1093.
    >> Share

  143. WU G, Zuck P, Goh SL, Milush JM, et al
    Gag p24 is a Marker of HIV Expression in Tissues and Correlates with Immune Response.
    J Infect Dis. 2021 Mar 9. pii: 6164924. doi: 10.1093.
    >> Share

  144. CHAZOT R, Botelho-Nevers E, Mariat C, Fresard A, et al
    Cystatin C and Urine Albumin to Creatinine Ratio Predict 5-Year Mortality and Cardiovascular Events in People Living With HIV.
    J Infect Dis. 2021;223:885-892.
    >> Share

  145. ZHOU S, Sizemore S, Moeser M, Zimmerman S, et al
    Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North Carolina.
    J Infect Dis. 2021;223:876-884.
    >> Share

  146. RICH SN, Poschman K, Hu H, Mavian C, et al
    Sociodemographic, Ecological, and Spatiotemporal Factors Associated with Human Immunodeficiency Virus Drug Resistance in Florida: A Retrospective Analysis.
    J Infect Dis. 2021;223:866-875.
    >> Share

    February 2021
  147. RYOM L, Lundgren JD, Reiss P, Ross M, et al
    The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study.
    J Infect Dis. 2021;223:632-637.
    >> Share

  148. AJAYKUMAR A, Zhu M, Kakkar F, Brophy J, et al
    Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
    J Infect Dis. 2021;223:621-631.
    >> Share

  149. POPOVICH KJ
    Using Genomic Sequencing to Delineate Community Networks of Methicillin-Resistant Staphylococcus aureus Transmission Among Men Who Have Sex With Men.
    J Infect Dis. 2021;223:543-546.
    >> Share

  150. VUJKOVIC-CVIJIN I, Sortino O, Verheij E, Wit FW, et al
    The complement pathway is activated in people with HIV and is associated with non-AIDS comorbidities.
    J Infect Dis. 2021 Feb 19. pii: 6144980. doi: 10.1093.
    >> Share

  151. CHUAYPEN N, Jinato T, Avihingsanon A, Chirapongsathorn S, et al
    Improvement of Gut Diversity and Composition after Direct-Acting Antivirals in HCV-Infected Patients with or without HIV Coinfection.
    J Infect Dis. 2021 Feb 17. pii: 6141513. doi: 10.1093.
    >> Share

  152. BANHART S, Selb R, Oehlmann S, Bender J, et al
    The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae, Germany, 2018.
    J Infect Dis. 2021 Feb 16. pii: 6138844. doi: 10.1093.
    >> Share

  153. LI C, Mori L, Valente ST
    The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A.
    J Infect Dis. 2021;223.
    >> Share

  154. SILICIANO JD, Siliciano RF
    Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
    J Infect Dis. 2021;223.
    >> Share

  155. LI JZ, Gandhi RT
    The Search for an HIV Cure: Where Do We Go From Here?
    J Infect Dis. 2021;223.
    >> Share

  156. LI Y, Mohammadi A, Li JZ
    Challenges and Promise of Human Immunodeficiency Virus Remission.
    J Infect Dis. 2021;223.
    >> Share

  157. ROSSIGNOL E, Alter G, Julg B
    Antibodies for Human Immunodeficiency Virus-1 Cure Strategies.
    J Infect Dis. 2021;223.
    >> Share

  158. KASEKE C, Tano-Menka R, Senjobe F, Gaiha GD, et al
    The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.
    J Infect Dis. 2021;223.
    >> Share

  159. ZHOU Y, Maldini CR, Jadlowsky J, Riley JL, et al
    Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy.
    J Infect Dis. 2021;223.
    >> Share

  160. FRANCESCHINI E, De Biasi S, Digaetano M, Bianchini E, et al
    Efficient T-Cell Compartment in HIV-Positive Patients Receiving Orthotopic Liver Transplant and Immunosuppressive Therapy.
    J Infect Dis. 2021;223:482-493.
    >> Share

  161. MAHOMED S, Garrett N, Baxter C, Abdool Karim Q, et al
    Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.
    J Infect Dis. 2021;223:370-380.
    >> Share

  162. CYKTOR JC, Bosch RJ, Mar H, Macatangay BJ, et al
    Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
    J Infect Dis. 2021;223:462-470.
    >> Share

  163. SERRANO-VILLAR S, Sanchez-Carrillo S, Talavera-Rodriguez A, Lelouvier B, et al
    Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery.
    J Infect Dis. 2021;223:471-481.
    >> Share

  164. CHITNENI P, Matthews LT
    The Other U=U. Untested and Untreated genital tract inflammation in people living with and exposed to HIV.
    J Infect Dis. 2021 Feb 10. pii: 6131968. doi: 10.1093.
    >> Share

  165. WALL KM, Karita E, Nyombayire J, Ingabire R, et al
    Genital abnormalities, hormonal contraception, and HIV transmission risk in Rwandan serodifferent couples.
    J Infect Dis. 2021 Feb 9. pii: 6131738. doi: 10.1093.
    >> Share

  166. RON R, Cabello A, Gosalbes MJ, Sanchez-Conde M, et al
    Exploiting the Microbiota for the Diagnosis of Anal Precancerous Lesions in Men Who Have Sex With Men.
    J Infect Dis. 2021 Feb 5. pii: 6129308. doi: 10.1093.
    >> Share

  167. MARGOLIS DM
    Measuring the Haystack's Needles.
    J Infect Dis. 2021;223:184-186.
    >> Share

    January 2021
  168. PARK SY, Faraci G, Murphy G, Pilcher C, et al
    Microdrop HIV sequencing for incidence and drug resistance surveillance.
    J Infect Dis. 2021 Jan 31. pii: 6124747. doi: 10.1093.
    >> Share

  169. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    >> Share

  170. EATON EF, Clement ME
    Wave the Yellow Flag: Why we should prioritize routine HIV and STI care now.
    J Infect Dis. 2021 Jan 27. pii: 6121541. doi: 10.1093.
    >> Share

  171. MASTRO TD, Bateganya M, Mahler H
    The need to optimize HIV test and treat in Africa.
    J Infect Dis. 2021 Jan 21. pii: 6104550. doi: 10.1093.
    >> Share

  172. GRABOWSKI MK, Patel EU, Nakigozi G, Ssempijja V, et al
    Prevalence and predictors of persistent HIV viremia and viral rebound following universal test and treat: a population-based study.
    J Infect Dis. 2021 Jan 20. pii: 6104546. doi: 10.1093.
    >> Share

  173. ROUTY JP, Isnard S
    Beyond the absence of CD4 T-cell count: A novel genetic CD4 T-cell deficiency disorder with a contingency plan.
    J Infect Dis. 2021 Jan 18. pii: 6103163. doi: 10.1093.
    >> Share

  174. STEIN CM, Benchek P, Bartlett J, Igo RP, et al
    Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa.
    J Infect Dis. 2021 Jan 5. pii: 6064776. doi: 10.1093.
    >> Share

  175. PILAROWSKI G, Lebel P, Sunshine S, Liu J, et al
    Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco.
    J Infect Dis. 2021 Jan 4. pii: 6061974. doi: 10.1093.
    >> Share

  176. MALTEZOU HC, Raftopoulos V, Vorou R, Papadima K, et al
    Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection.
    J Infect Dis. 2021 Jan 3. pii: 6060070. doi: 10.1093.
    >> Share

  177. GAISA MM, Sigel KM, Deshmukh AA, Lenskaya V, et al
    Comparing Anal Cancer Screening Algorithms Using Cytology and HPV DNA Testing in Three High-risk Populations.
    J Infect Dis. 2021 Jan 3. pii: 6060069. doi: 10.1093.
    >> Share

    December 2020
  178. JANKOWSKI CM, Wilson MP, MaWhinney S, Reusch J, et al
    Blunted muscle mitochondrial responses to exercise training in older adults with HIV.
    J Infect Dis. 2020 Dec 30. pii: 6055584. doi: 10.1093.
    >> Share

  179. KROEZE S, Rossouw TM, Steel HC, Wit FW, et al
    Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy.
    J Infect Dis. 2020 Dec 29. pii: 6054994. doi: 10.1093.
    >> Share

  180. RAWAT P, Brummel SS, Singh KK, Kim J, et al
    Genomics Links Inflammation with Neurocognitive Impairment in Children Living with Human Immunodeficiency Virus type-1.
    J Infect Dis. 2020 Dec 29. pii: 6054995. doi: 10.1093.
    >> Share

  181. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years.
    J Infect Dis. 2020 Dec 26. pii: 6053002. doi: 10.1093.
    >> Share

  182. SORTINO O, Dias J, Anderson M, Laidlaw E, et al
    Preserved MAIT cell numbers and function in idiopathic CD4 lymphocytopenia.
    J Infect Dis. 2020 Dec 25. pii: 6047591. doi: 10.1093.
    >> Share

  183. HEARPS AC, Angelovich TA, Trevillyan JM, Wong ME, et al
    Rosuvastatin therapy in people with HIV at intermediate cardiovascular risk does not decrease biomarkers of inflammation and immune activation.
    J Infect Dis. 2020 Dec 22. pii: 6044066. doi: 10.1093.
    >> Share

  184. MCMAHON DK, Zheng L, Cyktor JC, Aga E, et al
    A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).
    J Infect Dis. 2020 Dec 22. pii: 6043307. doi: 10.1093.
    >> Share

  185. MANION M, Dulanto Chiang A, Pei L, Wong CS, et al
    Disseminated Mycobacterium marinum in HIV unmasked by Immune Reconstitution Inflammatory Syndrome.
    J Infect Dis. 2020 Dec 18. pii: 6041190. doi: 10.1093.
    >> Share

  186. KIRKEGAARD-KLITBO DM, Bendtsen F, Lundgren J, de Knegt RJ, et al
    Increased prevalence of liver fibrosis in people living with HIV without viral hepatitis compared to population controls.
    J Infect Dis. 2020 Dec 15. pii: 6035145. doi: 10.1093.
    >> Share

  187. JIANG W, Luo Z, Stephenson S, Li H, et al
    Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury.
    J Infect Dis. 2020 Dec 15. pii: 6035152. doi: 10.1093.
    >> Share

  188. SUNDERMANN EE, Bondi MW, Campbell LM, Gouaux B, et al
    Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders.
    J Infect Dis. 2020 Dec 15. pii: 6034152. doi: 10.1093.
    >> Share

  189. MARTIN AR, Bender AM, Hackman J, Kwon KJ, et al
    Similar frequency and inducibility of intact HIV-1 proviruses in blood and lymph nodes.
    J Infect Dis. 2020 Dec 3. pii: 6017470. doi: 10.1093.
    >> Share

    November 2020
  190. JEYARAJAN AJ, Chung RT
    Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?
    J Infect Dis. 2020;222.
    >> Share

  191. ROCKSTROH JK, Boesecke C
    Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men.
    J Infect Dis. 2020;222.
    >> Share

  192. POYNTEN IM, Jin F, Garland SM, Hillman RJ, et al
    HIV, immune dysfunction and the natural history of anal high-risk human papillomavirus infection in gay and bisexual men.
    J Infect Dis. 2020 Nov 21. pii: 5998258. doi: 10.1093.
    >> Share

  193. FALCINELLI SD, Kilpatrick KW, Read J, Murtagh R, et al
    Longitudinal dynamics of intact HIV proviral DNA and outgrowth virus frequencies in a cohort of ART-treated individuals.
    J Infect Dis. 2020 Nov 20. pii: 5995716. doi: 10.1093.
    >> Share

  194. MEYER-MYKLESTAD MH, Medhus AW, Lorvik KB, Seljeflot I, et al
    HIV-infected immunological non-responders have colon-restricted gut mucosal immune dysfunction.
    J Infect Dis. 2020 Nov 20. pii: 5995605. doi: 10.1093.
    >> Share

  195. BERTAGNOLIO S, Hermans L, Jordan MR, Avila-Rios S, et al
    Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
    J Infect Dis. 2020 Nov 17. pii: 5986606. doi: 10.1093.
    >> Share

  196. LAPOINTE HR, Harrigan PR
    Human Immunodeficiency Virus Phylogenetics in the United States-and Elsewhere.
    J Infect Dis. 2020;222:1939-1940.
    >> Share

  197. DEESE J, Wang M, Lapple D, Nelson JAE, et al
    What's sex got to do with it? Understanding potential confounding and exposure misclassification in mechanistic sexually transmitted infection research.
    J Infect Dis. 2020 Nov 12. pii: 5974974. doi: 10.1093.
    >> Share

  198. DIETRICH LG, Thorball CW, Ryom L, Burkhalter F, et al
    Rapid Progression of Kidney Dysfunction in Swiss People Living with HIV: Contribution of Polygenic Risk Score and D:A:D Clinical Risk Score.
    J Infect Dis. 2020 Nov 5. pii: 5957071. doi: 10.1093.
    >> Share

  199. HALEY DF, Edmonds A, Ramirez C, French AL, et al
    Direct-acting antiviral Hepatitis C treatment cascade and barriers to treatment initiation among US men and women with and without HIV.
    J Infect Dis. 2020 Nov 3. pii: 5952700. doi: 10.1093.
    >> Share

    October 2020
  200. LUONG NGUYEN LB, Freedberg KA, Wanjala S, Maman D, et al
    Comparative effectiveness of interventions to improve the HIV continuum of care and HIV Pre-Exposure Prophylaxis in Kenya: a model-based analysis.
    J Infect Dis. 2020 Oct 27. pii: 5940739. doi: 10.1093.
    >> Share

  201. BREGLIO KF, Vinhaes CL, Arriaga MB, Nason M, et al
    Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with HIV.
    J Infect Dis. 2020 Oct 26. pii: 5940424. doi: 10.1093.
    >> Share

  202. DONOVAN J, Tram TTB, Phu NH, Hiep NTT, et al
    The influence of Strongyloides stercoralis co-infection on the presentation, pathogenesis and outcome of tuberculous meningitis.
    J Infect Dis. 2020 Oct 26. pii: 5940016. doi: 10.1093.
    >> Share

  203. MINAB R, Bu W, Nguyen H, Wall A, et al
    Maternal Epstein-Barr virus-specific antibodies and risk of infection in Ugandan infants.
    J Infect Dis. 2020 Oct 23. pii: 5936635. doi: 10.1093.
    >> Share

  204. DAVY-MENDEZ T, Napravnik S, Hogan BC, Althoff KN, et al
    Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015.
    J Infect Dis. 2020 Oct 21. pii: 5934541. doi: 10.1093.
    >> Share

  205. OLSON A, Coote C, Snyder-Cappione JE, Lin N, et al
    HIV-1 transcription but not intact provirus levels are associated with systemic inflammation.
    J Infect Dis. 2020 Oct 19. pii: 5930820. doi: 10.1093.
    >> Share

  206. YOSHIKAWA S, Yoshio S, Yoshida Y, Tsutsui Y, et al
    Impact of Immune Reconstitution-induced Hepatic Flare on HBsAg Loss in HBV/HIV-1-Coinfected Patients.
    J Infect Dis. 2020 Oct 19. pii: 5929874. doi: 10.1093.
    >> Share

  207. FICHTENBAUM CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, et al
    Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
    J Infect Dis. 2020 Oct 17. pii: 5928646. doi: 10.1093.
    >> Share

  208. SLYKER JA, Guthrie B, Pankau M, Tapia K, et al
    Cytomegalovirus and Epstein-Barr virus viremia are associated with HIV DNA levels in the reservoir of Kenyan infants on antiretroviral therapy.
    J Infect Dis. 2020 Oct 16. pii: 5926738. doi: 10.1093.
    >> Share

  209. IKEUCHI K, Adachi E, Sasaki T, Suzuki M, et al
    An outbreak of USA300 MRSA among people with HIV in Japan.
    J Infect Dis. 2020 Oct 15. pii: 5923726. doi: 10.1093.
    >> Share

  210. TIRABOSCHI JM, Rojas J, Zetterberg H, Blennow K, et al
    No changes in HIV suppression and inflammatory markers in CSF in patients randomly switched to DTG + 3TC (Spanish HIV/AIDS Research Network, PreEC/RIS 62).
    J Infect Dis. 2020 Oct 13. pii: 5922599. doi: 10.1093.
    >> Share

  211. LUSCOMBE CA, Avihingsanon A, Supparatpinyo K, Gatechompol S, et al
    Human immunodeficiency virus type-1 Vpu inhibitor, BIT225, in combination with 3-drug antiretroviral therapy modulates inflammation and immune cells functions.
    J Infect Dis. 2020 Oct 10. pii: 5920638. doi: 10.1093.
    >> Share

  212. KIRK GD, Astemborski J, Mehta SH, Ritter KD, et al
    Non-structured treatment interruptions are associated with higher HIV reservoir size measured by intact proviral DNA assay in people who inject drugs.
    J Infect Dis. 2020 Oct 10. pii: 5920557. doi: 10.1093.
    >> Share

    September 2020
  213. THUDIUM RF, Knudsen AD, Stemann JHV, Hove-Skovsgaard M, et al
    Independent Association of Interleukin 6 With Low Dynamic Lung Function and Airflow Limitation in Well-Treated People With Human Immunodeficiency Virus.
    J Infect Dis. 2020 Sep 24. pii: 5910961. doi: 10.1093.
    >> Share

  214. YANG CX, Schon E, Obeidat M, Kobor MS, et al
    Accelerated Epigenetic Aging and Methylation Disruptions Occur in Human Immunodeficiency Virus Infection Prior to Antiretroviral Therapy.
    J Infect Dis. 2020 Sep 22. pii: 5909822. doi: 10.1093.
    >> Share

    August 2020
  215. TESSEMA SK, Hathaway NJ, Teyssier NB, Murphy M, et al
    Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome.
    J Infect Dis. 2020 Aug 25. pii: 5897005. doi: 10.1093.
    >> Share

    July 2020
  216. CATLETT B, Bajis S, Starr M, Dore GJ, et al
    Evaluation of the Aptima HCV Quant Dx Assay for HCV RNA detection from finger-stick capillary dried blood spot and venepuncture-collected samples.
    J Infect Dis. 2020 Jul 25. pii: 5876378. doi: 10.1093.
    >> Share

  217. MCCREERY RJ, Florescu DF, Kalil AC
    Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus.
    J Infect Dis. 2020;222.
    >> Share

  218. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
    Extent of in-utero transfer of tenofovir from mother to fetus: a paired analysis of hair specimens collected at birth from a cohort in the United States.
    J Infect Dis. 2020 Jul 4. pii: 5867166. doi: 10.1093.
    >> Share

    June 2020
  219. BARROSO LF
    The Natural History of Anal Dysplasia: Unwrapping the Riddle to Find an Enigma.
    J Infect Dis. 2020;222:7-8.
    >> Share

    December 2019
  220. PHILLIPS A, Cambiano V, Johnson L, Nakagawa F, et al
    Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in KwaZulu-Natal accounting for drug resistance.
    J Infect Dis. 2019 Dec 18. pii: 5680588. doi: 10.1093.
    >> Share

  221. WIJERS JNAP, Dukers-Muijrers NHTM, van Liere GAFS, Dirks JAMC, et al
    Men and women have an equal oropharyngeal and anorectal Chlamydia trachomatis bacterial load: a comparison of three anatomic sites.
    J Infect Dis. 2019 Dec 16. pii: 5678512. doi: 10.1093.
    >> Share

    October 2019
  222. ELLSWORTH GB, Wilkin TJ
    Another Call for Widespread Human Papillomavirus Vaccination.
    J Infect Dis. 2019 Oct 5. pii: 5581839. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016